Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$1.62 - $2.28 $38,815 - $54,628
-23,960 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$1.87 - $2.8 $20,285 - $30,374
-10,848 Reduced 31.17%
23,960 $54,000
Q1 2021

May 14, 2021

BUY
$2.48 - $4.05 $23,884 - $39,005
9,631 Added 38.25%
34,808 $93,000
Q4 2020

Feb 25, 2021

BUY
$2.01 - $3.32 $50,605 - $83,587
25,177 New
25,177 $68,000

Others Institutions Holding PHIO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Phio Pharmaceuticals Corp.


  • Ticker PHIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,658,700
  • Market Cap $47.8M
  • Description
  • Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...
More about PHIO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.